Takeda Divesting Select OTC and Non-core Assets of takeda to Acino
Posted on25 Oct 2019
Tagsdisinvestment in pharma business, divestiment in pharma, Divestment in pharma, Takeda, Takeda acquires shire
Comments0
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription... Read More
Actavis to Divest U.S. Rights of Doryx to Mayne Pharma
Actavis plc entered into an agreement with Mayne Pharma for the divestment of U.S. rights to Doryx (acne) and related assets. Actavis... Read More